Little Benefit to Breakthrough Cancer Drugs.
Sign Up to like & getrecommendations! Published in 2018 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-nb2018-063
Abstract: Cancer drugs approved as FDA breakthrough therapies are not necessarily better than those approved through the traditional pathway: Although breakthrough-designated cancer drugs were approved in less time, a recent study reported, they were not associated… read more here.
Keywords: cancer drugs; benefit breakthrough; breakthrough cancer; little benefit ... See more keywords